Wilson’s disease is not something most people would think about, until it suddenly enters a conversation, often through a ...
Sarepta gains as enrollment begins in a new ENDEAVOR study cohort testing a sirolimus regimen to improve Elevidys safety in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results